
Edward Enninful confirmed that the March 2024 issue will be his last as British Vogue’s editor‑in‑chief . He will stay at Condé Nast as a global creative adviser . This piece reviews his impact on diversity, his influence on global style narratives, and what his new post could mean for fashion’s future.
When Edward Enninful became the editor‑in‑chief of British Vogue in 2017, he promised to broaden the magazine’s lens beyond its traditionally narrow focus. Over six years he delivered on that pledge, putting women of colour, activists, disabled models and plus‑sized bodies on covers that once celebrated a singular ideal of beauty. In July 2023 he announced plans to step down; last winter he confirmed that the March 2024 issue would be his final as editor . Rather than leaving Condé Nast, he will take on a newly created role as Vogue’s global creative and cultural adviser .
Enninful transformed British Vogue from an establishment title into a platform for diverse voices. He featured a hijab‑wearing model on the cover, devoted an issue to disabled talent and curated guest editors ranging from educators to politicians. The commercial success of these issues proved that inclusive representation can be profitable. In this sense, his tenure changed both perceptions and business models across publishing.
As global creative adviser, Enninful is charged with shaping Vogue’s worldwide vision while retaining an advisory position at British Vogue . The role is intentionally broad; he will scout emerging photographers, help design events and consult on brand extensions. By moving from day‑to‑day production to strategic guidance, he gains freedom to work across multiple titles and experiment with new formats. It also signals Condé Nast’s recognition that fashion magazines must operate as global brands rather than national franchises.

Fashion is both an art form and a cultural bellwether. Editors wield power over which designers, models and movements receive mainstream exposure. Enninful’s ascent in 2017 was a milestone for Black leadership in an industry that remains overwhelmingly white. His new post means that this perspective will influence global decision‑making—not just British pages. Moreover, his willingness to step aside hints at a shifting landscape in which legacy publications embrace collaborative leadership and decentralised creative control.
Vogue’s next UK editor has not been announced, but industry insiders hope that Enninful’s emphasis on diversity will continue. Meanwhile, his global remit could foster cross‑edition collaborations, amplify regional trends and support young creatives from under‑represented backgrounds. As fashion grapples with sustainability, inclusivity and digital experimentation, having a visionary who has championed social justice at the helm may accelerate change.

Kelly Dowd, MBA, MA, is an author, systems architect, and Editor-in-Chief of WTM MEDIA. Dowd examines the intersections of people, power, politics, and design—bringing clarity to the forces that shape democracy, influence culture, and determine the future of global society. Their work blends rigorous analysis with cultural insight, inviting readers to think critically about the world and its unfolding narratives.

For most of aviation history, human flight has required an aircraft: a machine large enough to generate lift, carry fuel, accommodate passengers, and surround its occupants with an engineered structure. Emerging personal-flight technologies are beginning to loosen that relationship. Jet suits, powered wings, compact electric vertical-lift systems, autonomous drones, and increasingly sophisticated flight-control technologies suggest that aviation may eventually encompass machines worn, mounted, or summoned rather than conventionally boarded. The viral spectacle is irresistible. A person rises from the ground, accelerates over water, and appears to have acquired a superpower. Yet spectacle obscures the engineering. Human-scale powered flight confronts brutal constraints involving energy density, heat, noise, stability, endurance, payload, weather, redundancy, training, regulation, and the consequences of mechanical failure. A technology can fly successfully and still be unsuitable for mass transportation. That distinction is central to understanding personal aviation. The most plausible near-term applications are unlikely to involve commuters casually flying between homes and offices. Specialist environments — emergency response, defence, offshore infrastructure, inaccessible terrain, inspection, rescue, and certain industrial operations — provide a more credible pathway because the economic value of reaching somewhere quickly can outweigh the technology’s considerable limitations. The deeper development, however, extends beyond jet suits. Aviation is becoming computational. Sensors can stabilise machines faster than human reflexes. Software can continuously adjust thrust. Lightweight materials reduce mass. Autonomous navigation increasingly separates piloting from constant manual control. Electric propulsion enables aircraft configurations that would have been impractical under traditional mechanical architectures. The result is not necessarily the death of the aeroplane. Commercial aircraft remain extraordinarily efficient at moving large numbers of people over long distances. Instead, aviation may be fragmenting into a richer ecosystem: aircraft for distance, drones for autonomous logistics, eVTOL systems for specialised regional movement, and wearable or highly compact systems for particular human-scale missions. The important question is therefore no longer simply, “Can a person fly without an aeroplane?” We already know that certain machines can make that possible. The better question is: when does removing the aircraft make flight more useful?

Canada’s Medical Assistance in Dying programme has moved an ancient human question into modern medicine: when suffering becomes intolerable, who should have authority over how life ends? In 2024, 16,499 people received MAID—5.1 per cent of deaths in Canada. Yet the headline conceals crucial distinctions: 95.6 per cent were people whose natural deaths were reasonably foreseeable; 4.4 per cent were not. Most recipients had received palliative care, while disability advocates, clinicians, ethicists and policymakers continue to dispute whether safeguards can adequately separate autonomous choice from suffering intensified by inadequate social support. The future makes the question harder. Medicine is simultaneously extending life, managing once-fatal disease, expanding organ transplantation and developing technologies that could prolong healthy longevity. A civilisation capable of keeping people alive for longer must therefore become equally sophisticated about what makes continued life worth living. The central question is larger than MAID: can a society protect the right to choose death without allowing failures of care to narrow the possibility of choosing life?

For four decades, the central challenge of HIV medicine has been control. Antiretroviral therapy can suppress the virus so effectively that people living with HIV can lead long, healthy lives and, when viral load remains undetectable, do not transmit HIV sexually. Yet treatment does not remove the latent viral reservoir embedded within the body, meaning therapy usually must continue. A developing body of HIV research is asking a different question: rather than continually suppressing an active virus, could medicine make its hidden genetic machinery remain silent? A 2025 Science Advances study found that an HIV-derived antisense transcript known as AST could reinforce viral latency in cells from people receiving treatment. Subsequent research confirmed that HIV antisense transcripts occur naturally in people living with the virus. These findings do not constitute an HIV cure. They reveal something potentially more consequential: another biological mechanism that scientists may eventually learn to manipulate. The larger intelligence is about where medicine may be heading—from repeatedly controlling disease towards redesigning the conditions that allow disease to persist.